India

Dr Reddy's sells off Tennessee antibiotics facility in restructuring push
Dr Reddy's sells off Tennessee antibiotics facility in restructuring push
Biopharma Dive
Dr Reddy's
India
Tennessee
drug manufacturing
Flag link:
India Orders Payments From J&J’s DePuy Over ‘Faulty’ Hip Implants
India Orders Payments From J&J’s DePuy Over ‘Faulty’ Hip Implants
RAPS.org
India
DePuy
JNJ
hip implants
Flag link:
GSK seeks mid-Sept bids for $4 billion Indian Horlicks unit - sources
GSK seeks mid-Sept bids for $4 billion Indian Horlicks unit - sources
Yahoo/Reuters
GSK
M&A
Horlicks
India
Flag link:
Sun Pharma receives USFDA nod for ophthalmic solution used to treat dry eye disease
Sun Pharma receives USFDA nod for ophthalmic solution used to treat dry eye disease
Economic Times, India
Sun Pharma
FDA
India
dry eye disease
Cequa
Flag link:
As U.S. trade war escalates, China rolls out red carpet for Indian drugmakers
As U.S. trade war escalates, China rolls out red carpet for Indian drugmakers
Fierce Pharma
China
India
trade war
drug importation
tarriffs
Flag link:
Sun Pharma gets reprieve as FDA clears key Halol plant
Sun Pharma gets reprieve as FDA clears key Halol plant
Biopharma Dive
Sun Pharma
drug manufacturing
Halol
FDA
India
Flag link:
Aurobindo bids $1.6B for Novartis' U.S. dermatology generics: report
Aurobindo bids $1.6B for Novartis' U.S. dermatology generics: report
Fierce Pharma
Aurobindo
Novartis
Sandoz
M&A
dermatology
India
Flag link:
The difficult momentum of Indian pharma sector
The difficult momentum of Indian pharma sector
GoinPharma
India
generics
Sun Pharma
Cipla
Dr Reddy's
Lupin
Flag link:
Merck KGaA injects $47M into Asian manufacturing efforts
Merck KGaA injects $47M into Asian manufacturing efforts
Biopharma Dive
Merck KGaA
drug manufacturing
Asia
India
South Korea
Flag link:
Indian, Chinese drugmakers eye Sanofi's European generics unit for $2B deal: report
Indian, Chinese drugmakers eye Sanofi's European generics unit for $2B deal: report
Fierce Pharma
Sanofi
Europe
generics
China
India
Flag link:
Biocon and Mylan say their plant is good to go as FDA decision nears for their Herceptin copy
Biocon and Mylan say their plant is good to go as FDA decision nears for their Herceptin copy
Fierce Pharma
Biocon
Mylan Labs
FDA
Herceptin
drug manufacturing
biologics
India
Flag link:
Indian pharma sector keeps consolidating: Torrent acquires Unichem Laboratories
Indian pharma sector keeps consolidating: Torrent acquires Unichem Laboratories
GoinPharma
India
Torrent Pharmaceuticals
Unichem Laboratories
M&A
Flag link:
Medtech Industry Frowns on India Price Caps
Medtech Industry Frowns on India Price Caps
Medical Device and Diagnostic Industry
devices
India
Flag link:
China’s big pharma targets India
China’s big pharma targets India
GoinPharma
China
India
Fosun Pharmaceutical
Symbiotec
Flag link:
Indian gov’t mulls price cap on ‘essential’ medical devices
Indian gov’t mulls price cap on ‘essential’ medical devices
Mass Device
India
devices
Flag link:
OrbiMed lines up $551M gamble on China, India biotech sectors
OrbiMed lines up $551M gamble on China, India biotech sectors
Endpoints
OrbiMed
China
India
biotech
venture capital
Flag link:
With U.S. Generic Drug Market in Chaos, Indian Upstarts Rise
With U.S. Generic Drug Market in Chaos, Indian Upstarts Rise
Bloomberg
generics
India
Flag link:
Pfizer Wins Indian Patent on Prevnar 13 Vaccine
Pfizer Wins Indian Patent on Prevnar 13 Vaccine
RAPS.org
Pfizer
India
Prevnar 13
vaccine
patents
Flag link:
Intas Pharmaceuticals offered $1.5bn for 3 divisions of Teva’s in Europe
Intas Pharmaceuticals offered $1.5bn for 3 divisions of Teva’s in Europe
GoInPharma
Intas
India
M&A
Teva Pharmaceutical
Europe
Women's Health
oncology
pain management
Flag link:
FDA Collaborates to Promote Safety, Quality in Clinical Trials Done in India
FDA Collaborates to Promote Safety, Quality in Clinical Trials Done in India
Mass Device
FDA
India
clinical trials
Flag link:

Pages